Traduction de «concerns the means used » (Néerlandais → Français) :

Another aspect of this finding which has to do with the relation between depression and suicide concerns the means used to carry out the act: sometimes antidepressants prescribed for treating depression are used to commit suicide.
Un autre aspect de ce constat qui relève de la relation entre dépression et suicide concerne le moyen utilisé pour commettre l’acte: les antidépresseurs prescrits pour le traitement de la dépression sont parfois utilisés à des fins suicidaires.

With no systematic records available of the attempted suicides that have been seen by a doctor, the data concerning attempted suicides are also often collected by means of general population surveys.
En l’absence d’enregistrement systématique des tentatives de suicide aboutissant auprès d’un médecin, les données sur les tentatives de suicide sont souvent recueillies également par le biais d’enquête en population générale.

Moreover, they use more “violent” means of committing suicide than women.
Ils ont, de plus, recours à des moyens plus « violents » de se donner la mort que les femmes.

Nevertheless, some studies, including the 2004 Belgian Health Survey discussed above, throw some light on this problem in so far as they focus on measuring notions such as psychological illbeing (Book II of the Health Interview Survey – Belgium 2004, pp 204-209): “The psychological well-being assessed in the 2004 Belgian Health Survey is measured by means of an instrument (GHQ-12, General Health Questionnaire) that uses scores ranging from 0 to 12. A higher score indicates a higher probability/severity of psychological ill-being.
« Le bien-être/mal-être psychologique évalué dans l’enquête de santé en Belgique de 2004 est mesuré grâce à un outil (GHQ-12, General Health Questionnaire) dont l’échelle de mesure va de 0 à 12, où un score plus élevé indique une plus grande probabilité/sévérité du mal-être psychologique.

What makes this phenomenon all the more worrying is that the death rate increases with the number of attempted suicides, desperate individuals making use of increasingly violent means.
Ce phénomène est d’autant plus inquiétant que la létalité augmente au fil des tentatives, le désespéré ayant recours à des moyens de plus en plus violents.

Our policy is based on the concept of the 3Rs: reduce, refine, replace. This means that we reduce animal experimentation wherever possible, refine all experiments to ensure the minimum number of animals are used, and seek alternatives to animal testing.
Notre politique se résume en trois points : limiter au strict nécessaire les expérimentations animales ; concevoir des essais qui réduisent au minimum le nombre d’animaux utilisés ; chercher des solutions alternatives aux essais sur les animaux.

The following figure mentions the means used in Belgium.
Le tableau suivant présente les moyens utilisés en Belgique.

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

Figure 6. Gender-based comparison of the percentages of the means used in 1995.
Figure 6: Comparaison entre sexes des pourcentages des moyens utilisés pour l’année 1995.

- wederzijdse erkenningsprocedure en gedecentraliseerde procedure MRP/DCP (PPT, 248 Kb) ; Strategy paper (PDF, 13.4 Kb) for RMS request in view of the Decentralized procedure (DCP) concerning medicinal products for human use (update 04/2013) ; DCP Request Template (DOC, 121 Kb)
- procédure de reconnaissance mutuelle et procédure décentralisée MRP/DCP (PPT, 248 Kb) ; Strategy paper (PDF, 13.4 Kb) for RMS request in view of the Decentralized Procedure (DCP) concenring medicinal products for human use (update 04/2013) ; Template for DCP Request (DOC, 121 Kb)